1,3-Benzodioxolyl-N-methylpentanamine
Appearance
(Redirected from MBDP)
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Names | |
---|---|
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-methylpentan-2-amine | |
Other names
3,4-Methylenedioxy-α-propyl-N-methyl-2-phenethylamine
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C13H19NO2 | |
Molar mass | 221.30 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
N-Methyl-1,3-benzodioxolylpentanamine (MBDP; Methyl-K, UWA-091), also known as 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, is a psychoactive drug of the phenethylamine chemical class. It is the N-methyl analogue of 1,3-benzodioxolylpentanamine (BDP; K). Methyl-K was first synthesized by Alexander Shulgin ("Sasha" Shulgin). In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 100 mg, and the duration is unknown.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Methyl-K.
Legality
[edit]United Kingdom
[edit]This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
[edit]- Pentylone (bk-MBDP)
- Ethylbenzodioxolylpentanamine (EBDP; Ethyl-K)
- Methylbenzodioxolylbutanamine (MBDB; Methyl-J)
- UWA-101
References
[edit]- ^ Methyl-K entry in PiHKAL
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.